Tirzepatide showed a noninferior reduction in all-cause mortality (HR 0.88, 95% CI 0.68 to 1.16), myocardial infarction (HR 0.91, 95% CI 0.73 to 1.12) and stroke (HR 0.78, 95% CI 0.59 to 1.03) compared to dulaglutide, although CIs remained compatible with no difference
Complete non-response often points to receptor-level issues, either genetic polymorphisms that alter GLP-1 receptor binding, or downstream signaling problems that prevent the receptor activation from translating into metabolic changes
Meanwhile, the spending level in Finland, Denmark, Ireland, France, Luxembourg, Belgium, Sweden, the Netherlands, and Austria is above the average of USD 3,814, thus enhancing the market exposure
Industrywide, sales of those drugs have tripled since 2020
More and more individuals who have used GLP-1 medications like Ozempic, Wegovy, Rybelsus, Saxenda, Mounjaro, and others continue to file lawsuits over gastrointestinal injuries
The Hint app, with its Pro and Premium features, provides comprehensive support to help you achieve your weight loss goals effectively and sustainably
